APO RESEARCH · REPORT
Metronidazole
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Product & engineering
Understand the product.
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Selected research
Industry Research
Metronidazole Industry Research Report 2026
Market perspective
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Global Metronidazole key players include CordenPharma Farchemia, Tongji Pharmaceutical, Aarti Drugs, Manav Drugs, etc.
China is the largest market, with a share about 90%, followed by India, and Europe, both have a share over 10 percent.
Read the full market overview
In terms of product, Glyoxal Process is the largest segment, with a share over 85%. And in terms of application, the largest application is Metronidazole Tablets, followed by Metronidazole Capsule, Metronidazole Injection, etc.
Report Scope
This report quantifies the global Metronidazole market in terms of revenue (US$ million) and, where applicable, sales volume (MT), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/MT) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Metronidazole Market by Company
Hongyuan Pharmaceutical
Yinhe Aarti Pharmaceutical
Saikang Pharmaceutical
Zhongan Pharmaceutical
Wuyao Pharmaceutical
Yichang Changjiang Pharmaceutical
Tongji Pharmaceutical
Hongda Pharmaceutical
Topsun Pharmaceutical
Unichem Laboratories
CordenPharma Farchemia
API Polpharma
Manav Drugs
Aarey Drugs & Pharmaceuticals
Aarti Drugs
Metronidazole Segment by Type
Glyoxal Process
Ethidene Diamine Process
Others
Metronidazole Segment by Application
Metronidazole Tablets
Metronidazole Capsule
Metronidazole Injection
Others
Metronidazole Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metronidazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metronidazole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metronidazole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Metronidazole manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Metronidazole by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Metronidazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glyoxal Process
- Ethidene Diamine Process
- Others
Applications
- Metronidazole Tablets
- Metronidazole Capsule
- Metronidazole Injection
- Others
Companies covered
- Hongyuan Pharmaceutical
- Yinhe Aarti Pharmaceutical
- Saikang Pharmaceutical
- Zhongan Pharmaceutical
- Wuyao Pharmaceutical
- Yichang Changjiang Pharmaceutical
- Tongji Pharmaceutical
- Hongda Pharmaceutical
- Topsun Pharmaceutical
- Unichem Laboratories
- CordenPharma Farchemia
- API Polpharma
- Manav Drugs
- Aarey Drugs & Pharmaceuticals
- Aarti Drugs
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Metronidazole Market Size (2021-2032)
- 2.2.2 Global Metronidazole Sales (2021-2032)
- 2.2.3 Global Metronidazole Market Average Price (2021-2032)
- 2.3 Metronidazole by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Glyoxal Process
- 2.3.3 Ethidene Diamine Process
- 2.3.4 Others
- 2.4 Metronidazole by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Metronidazole Tablets
- 2.4.3 Metronidazole Capsule
- 2.4.4 Metronidazole Injection
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Metronidazole Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Metronidazole Sales (MT) of Manufacturers (2021-2026)
- 3.3 Global Metronidazole Revenue of Manufacturers (2021-2026)
- 3.4 Global Metronidazole Average Price by Manufacturers (2021-2026)
- 3.5 Global Metronidazole Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Metronidazole, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Metronidazole, Product Type & Application
- 3.8 Global Manufacturers of Metronidazole, Established Date
- 3.9 Global Metronidazole Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Hongyuan Pharmaceutical
- 4.1.1 Hongyuan Pharmaceutical Company Information
- 4.1.2 Hongyuan Pharmaceutical Business Overview
- 4.1.3 Hongyuan Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Hongyuan Pharmaceutical Metronidazole Product Portfolio
- 4.1.5 Hongyuan Pharmaceutical Recent Developments
- 4.2 Yinhe Aarti Pharmaceutical
- 4.2.1 Yinhe Aarti Pharmaceutical Company Information
- 4.2.2 Yinhe Aarti Pharmaceutical Business Overview
- 4.2.3 Yinhe Aarti Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Yinhe Aarti Pharmaceutical Metronidazole Product Portfolio
- 4.2.5 Yinhe Aarti Pharmaceutical Recent Developments
- 4.3 Saikang Pharmaceutical
- 4.3.1 Saikang Pharmaceutical Company Information
- 4.3.2 Saikang Pharmaceutical Business Overview
- 4.3.3 Saikang Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Saikang Pharmaceutical Metronidazole Product Portfolio
- 4.3.5 Saikang Pharmaceutical Recent Developments
- 4.4 Zhongan Pharmaceutical
- 4.4.1 Zhongan Pharmaceutical Company Information
- 4.4.2 Zhongan Pharmaceutical Business Overview
- 4.4.3 Zhongan Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Zhongan Pharmaceutical Metronidazole Product Portfolio
- 4.4.5 Zhongan Pharmaceutical Recent Developments
- 4.5 Wuyao Pharmaceutical
- 4.5.1 Wuyao Pharmaceutical Company Information
- 4.5.2 Wuyao Pharmaceutical Business Overview
- 4.5.3 Wuyao Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Wuyao Pharmaceutical Metronidazole Product Portfolio
- 4.5.5 Wuyao Pharmaceutical Recent Developments
- 4.6 Yichang Changjiang Pharmaceutical
- 4.6.1 Yichang Changjiang Pharmaceutical Company Information
- 4.6.2 Yichang Changjiang Pharmaceutical Business Overview
- 4.6.3 Yichang Changjiang Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Yichang Changjiang Pharmaceutical Metronidazole Product Portfolio
- 4.6.5 Yichang Changjiang Pharmaceutical Recent Developments
- 4.7 Tongji Pharmaceutical
- 4.7.1 Tongji Pharmaceutical Company Information
- 4.7.2 Tongji Pharmaceutical Business Overview
- 4.7.3 Tongji Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Tongji Pharmaceutical Metronidazole Product Portfolio
- 4.7.5 Tongji Pharmaceutical Recent Developments
- 4.8 Hongda Pharmaceutical
- 4.8.1 Hongda Pharmaceutical Company Information
- 4.8.2 Hongda Pharmaceutical Business Overview
- 4.8.3 Hongda Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hongda Pharmaceutical Metronidazole Product Portfolio
- 4.8.5 Hongda Pharmaceutical Recent Developments
- 4.9 Topsun Pharmaceutical
- 4.9.1 Topsun Pharmaceutical Company Information
- 4.9.2 Topsun Pharmaceutical Business Overview
- 4.9.3 Topsun Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Topsun Pharmaceutical Metronidazole Product Portfolio
- 4.9.5 Topsun Pharmaceutical Recent Developments
- 4.10 Unichem Laboratories
- 4.10.1 Unichem Laboratories Company Information
- 4.10.2 Unichem Laboratories Business Overview
- 4.10.3 Unichem Laboratories Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Unichem Laboratories Metronidazole Product Portfolio
- 4.10.5 Unichem Laboratories Recent Developments
- 4.11 CordenPharma Farchemia
- 4.11.1 CordenPharma Farchemia Company Information
- 4.11.2 CordenPharma Farchemia Business Overview
- 4.11.3 CordenPharma Farchemia Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 CordenPharma Farchemia Metronidazole Product Portfolio
- 4.11.5 CordenPharma Farchemia Recent Developments
- 4.12 API Polpharma
- 4.12.1 API Polpharma Company Information
- 4.12.2 API Polpharma Business Overview
- 4.12.3 API Polpharma Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 API Polpharma Metronidazole Product Portfolio
- 4.12.5 API Polpharma Recent Developments
- 4.13 Manav Drugs
- 4.13.1 Manav Drugs Company Information
- 4.13.2 Manav Drugs Business Overview
- 4.13.3 Manav Drugs Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Manav Drugs Metronidazole Product Portfolio
- 4.13.5 Manav Drugs Recent Developments
- 4.14 Aarey Drugs & Pharmaceuticals
- 4.14.1 Aarey Drugs & Pharmaceuticals Company Information
- 4.14.2 Aarey Drugs & Pharmaceuticals Business Overview
- 4.14.3 Aarey Drugs & Pharmaceuticals Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Aarey Drugs & Pharmaceuticals Metronidazole Product Portfolio
- 4.14.5 Aarey Drugs & Pharmaceuticals Recent Developments
- 4.15 Aarti Drugs
- 4.15.1 Aarti Drugs Company Information
- 4.15.2 Aarti Drugs Business Overview
- 4.15.3 Aarti Drugs Metronidazole Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Aarti Drugs Metronidazole Product Portfolio
- 4.15.5 Aarti Drugs Recent Developments
5 Global Metronidazole Market Scenario by Region
- 5.1 Global Metronidazole Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Metronidazole Sales by Region: 2021-2032
- 5.2.1 Global Metronidazole Sales by Region: 2021-2026
- 5.2.2 Global Metronidazole Sales by Region: 2027-2032
- 5.3 Global Metronidazole Revenue by Region: 2021-2032
- 5.3.1 Global Metronidazole Revenue by Region: 2021-2026
- 5.3.2 Global Metronidazole Revenue by Region: 2027-2032
- 5.4 North America Metronidazole Market Facts & Figures by Country
- 5.4.1 North America Metronidazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Metronidazole Sales by Country (2021-2032)
- 5.4.3 North America Metronidazole Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Metronidazole Market Facts & Figures by Country
- 5.5.1 Europe Metronidazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Metronidazole Sales by Country (2021-2032)
- 5.5.3 Europe Metronidazole Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Metronidazole Market Facts & Figures by Country
- 5.6.1 Asia Pacific Metronidazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Metronidazole Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Metronidazole Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Metronidazole Market Facts & Figures by Country
- 5.7.1 South America Metronidazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Metronidazole Sales by Country (2021-2032)
- 5.7.3 South America Metronidazole Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Metronidazole Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Metronidazole Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Metronidazole Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Metronidazole Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Metronidazole Sales by Type (2021-2032)
- 6.1.1 Global Metronidazole Sales by Type (2021-2032) & (MT)
- 6.1.2 Global Metronidazole Sales Market Share by Type (2021-2032)
- 6.2 Global Metronidazole Revenue by Type (2021-2032)
- 6.2.1 Global Metronidazole Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Metronidazole Revenue Market Share by Type (2021-2032)
- 6.3 Global Metronidazole Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Metronidazole Sales by Application (2021-2032)
- 7.1.1 Global Metronidazole Sales by Application (2021-2032) & (MT)
- 7.1.2 Global Metronidazole Sales Market Share by Application (2021-2032)
- 7.2 Global Metronidazole Revenue by Application (2021-2032)
- 7.2.1 Global Metronidazole Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Metronidazole Revenue Market Share by Application (2021-2032)
- 7.3 Global Metronidazole Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Metronidazole Value Chain Analysis
- 8.1.1 Metronidazole Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Metronidazole Production Mode & Process
- 8.2 Metronidazole Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Metronidazole Distributors
- 8.2.3 Metronidazole Customers
9 Global Metronidazole Analyzing Market Dynamics
- 9.1 Metronidazole Industry Trends
- 9.2 Metronidazole Industry Drivers
- 9.3 Metronidazole Industry Opportunities and Challenges
- 9.4 Metronidazole Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst